lab talk: fgfr3 testing in bladder cancer by dr. michael hubank
Published 1 month ago • 444 plays • Length 56:45Download video MP4
Download video MP3
Similar videos
-
35:34
webinar: fgfr testing for advanced bladder cancer (2020.03.05)
-
12:14
the latest in bladder cancer with fgfr 2 and 3 mutations
-
2:48
fgfr inhibitors in bladder cancer
-
6:47
fgfr screening - the pathologist perspective
-
7:18
case 3: experience with fgfr-targeted therapies in bladder cancer
-
11:42
fgfr inhibitors in bladder cancer: testing, screening and highlights from asco 2020
-
3:00
fgfr3 inhibition by infigratinib for upper tract urothelial cancer
-
4:11
an overview of targeted fgfr3 therapy in bladder cancer with dr. siefker-radtke
-
10:21
clarify: phase 3 diagnostic trial of 64cu-sar-bispsma pet imaging in prostate cancer before surgery
-
42:34
reading and understanding your lab report
-
16:35
everything you need to know about dlbcl | #dlbcl
-
2:29
additional insights: experience with fgfr inhibitors in bladder cancer
-
1:40
liquid biopsy analysis of fgfr3 and pik3ca for disease surveillance in bladder cancer
-
46:19
targeting fgfr in urothelial carcinoma
-
4:03
fgfr inhibitors for cca & bladder cancer
-
1:27
thor-2 cohort 3 interim analysis: erdafitinib in intermediate-risk nmibc with fgfr3/2 alterations
-
5:24
case 3: fgfr-targeted therapy adverse events in bladder cancer
-
1:47
dr. sonpavde on the safety profile of erdafitinib in bladder cancer
-
1:18:20
lustgartenlive!: clinical advances from the lab to you
-
1:43
dr christian frezza's lab overview
-
1:51
dr. siefker-radtke on the treatment of fgfr-altered bladder cancer